Jaydon Hermann

Meet Jaydon Hermann, the driving force behind Business Press Daily. As our Editor-in-Chief, Jaydon is dedicated to delivering the latest and most insightful news in the business world. With a passion for uncovering stories that matter, Jaydon leads our team in providing you with the most up-to-date and informative newsroom experience.

Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data

Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data

Aykut Karahan | Istock | Getty Images Shares of Structure Therapeutics rose more than 30% on Friday after the biotech startup’s experimental obesity pill succeeded in a small early-stage trial.  The once-daily drug helped overweight or obese participants reduce up

Shares of biotech startup Structure Therapeutics surge more than 30% on promising obesity pill data Read More »

Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly 0 million

Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million

A view of a plastic model of a stomach during an interview with Doctor Thomas Horbach, specialist in surgery, visceral surgery and nutritional medicine on Novo Nordisk, which will start selling its hugely popular obesity drug Wegovy in Germany later

Ad spending for obesity, diabetes drugs is soaring this year, as drugmakers shell out nearly $500 million Read More »

BPD LINK ENGINE ACTIVE ?